Betashares Global Healthcare ETF - Currency Hedged
What DRUG does
The Betashares Global Healthcare ETF - Currency Hedged (ticker: DRUG) allows investors to gain exposure to a diverse range of global healthcare companies. This ETF invests in a broad selection of healthcare firms, including those involved in pharmaceuticals, biotechnology, and medical equipment, providing a way to benefit from the growth and innovation in the healthcare sector worldwide. The currency hedging feature helps protect Australian investors from fluctuations in foreign exchange rates, ensuring that returns are more closely aligned with the actual performance of the underlying investments. With a management fee of 0.57%, this ETF offers a straightforward way to invest in the global healthcare industry while managing currency risk.
Management Fee
0.57%
Distribution Yield
0.39%
Fund Under Management
$182M
+10.45M
Monthly Liquidity
8.69%
Spread
0.20%
Last Price
...
Product Type
ETFTop Holdings
| Holding | Weight |
|---|---|
| Eli Lilly & Co | 7.90% |
| Johnson & Johnson | 7.40% |
| AbbVie Inc | 5.40% |
| Roche Holding AG | 5.10% |
| AstraZeneca PLC | 4.70% |
| Novartis AG | 4.40% |
| UnitedHealth Group Inc | 4.20% |
| Merck & Co Inc | 3.80% |
| Thermo Fisher Scientific Inc | 3.60% |
| Novo Nordisk A/S | 3.40% |
Sector Exposure
Country Exposure
Monthly fund flows
Monthly Flow
+$11.24M
12-Month Flow
$-16.88M
Trading Activity
Transacted Value
$16M
Volume
1,819,588
Number of Trades
1,982
Monthly Liquidity
8.69%
Performance
1 Month
-0.57%
1 Year
12.22%
3 Year
5.04%
5 Year
6.69%
Total Return
Sector Exposure
Country Exposure
Top Holdings
Share Price Chart
Related ETFs
Betashares Global Royalties ETF
Betashares India Quality ETF
Betashares FTSE 100 Currency Hedged ETF
Betashares Global Robotics and Artificial Intelligence ETF
Betashares MSCI Emerging Markets Complex ETF
Betashares FTSE 100 ETF
Resources
Want Expert ETF Portfolio Guidance?
Get access to Owen Rask's expert ETF portfolios, ongoing research, and 10+ investing courses.
✓ 50+ years experience • ASIC licensed • Cancel anytime
Should you buy Betashares Global Healthcare ETF - Currency Hedged right now?
While DRUG looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now